Andrew D. Rule
Auto-generated profile, based on publicly available information

Andrew D. Rule

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Advances in Chronic Kidney Disease
Verified
Journal Article
Closed access
PDF file
ADAleksandar Denic
Aleksandar Denic
RGRichard J. Glassock
Richard J. Glassock
ARAndrew D. Rule
Andrew D. Rule

8 July 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
ADAleksandar Denic
Aleksandar Denic
JLJohn C. Lieske
John C. Lieske
HCHarini A. Chakkera
Harini A. Chakkera
EPEmilio D. Poggio
Emilio D. Poggio
MAMariam P. Alexander
Mariam P. Alexander
ARAndrew D. Rule
Andrew D. Rule
Nephron number may be an important determinant of kidney health but has been difficult to study in living humans. We evaluated 1638 living kidney donors at Mayo Clinic (MN and AZ sites) and Cleveland Clinic. We obtained cortical volumes of both kidneys from predonation computed tomography scans. At the time of kidney transplant, we obtained and analyzed the sections of a biopsy specimen of the cortex to determine the density of both nonsclerotic and globally sclerotic glomeruli; the total number of glomeruli was estimated from cortical volume×glomerular density. Donors 18–29 years old had a mean 990,661 nonsclerotic glomeruli and 16,614 globally sclerotic glomeruli per kidney, which progressively decreased to 520,410 nonsclerotic glomeruli per kidney and increased to 141,714 globally sclerotic glomeruli per kidney in donors 70–75 years old. Between the youngest and oldest age groups, the number of nonsclerotic glomeruli decreased by 48%, whereas cortical volume decreased by only 16% and the proportion of globally sclerotic glomeruli on biopsy increased by only 15%. Clinical characteristics that independently associated with fewer nonsclerotic glomeruli were older age, shorter height, family history of ESRD, higher serum uric acid level, and lower measured GFR. The incomplete representation of nephron loss with aging by either increased glomerulosclerosis or by cortical volume decline is consistent with atrophy and reabsorption of globally sclerotic glomeruli and hypertrophy of remaining nephrons. In conclusion, lower nephron number in healthy adults associates with characteristics reflective of both lower nephron endowment at birth and subsequent loss of nephrons.

8 August 2017 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
MHMusab S. Hommos
Musab S. Hommos
RGRichard J. Glassock
Richard J. Glassock
ARAndrew D. Rule
Andrew D. Rule
Aging is associated with significant changes in structure and function of the kidney, even in the absence of age-related comorbidities. On the macrostructural level, kidney cortical volume decreases, surface roughness increases, and the number and size of simple renal cysts increase with age. On the microstructural level, the histologic signs of nephrosclerosis (arteriosclerosis/arteriolosclerosis, global glomerulosclerosis, interstitial fibrosis, and tubular atrophy) all increase with age. The decline of nephron number is accompanied by a comparable reduction in measured whole-kidney GFR. However, single-nephron GFR remains relatively constant with healthy aging as does glomerular volume. Only when glomerulosclerosis and arteriosclerosis exceed that expected for age is there an increase in single-nephron GFR. In the absence of albuminuria, age-related reduction in GFR with the corresponding increase in CKD (defined by an eGFR<60 ml/min per 1.73 m2) has been shown to associate with a very modest to no increase in age-standardized mortality risk or ESRD. These findings raise the question of whether disease labeling of an age-related decline in GFR is appropriate. These findings also emphasize the need for a different management approach for many elderly individuals considered to have CKD by current criteria.

4 August 2020 in Nature Reviews Nephrology
Verified
Journal Article
Closed access
PDF file
CTCharat Thongprayoon
Charat Thongprayoon
AKAmy Krambeck
Amy Krambeck
ARAndrew D. Rule
Andrew D. Rule

1 February 2021 in Annals of Internal Medicine
Verified
Journal Article
Closed access
HPHans Pottel
Hans Pottel
JBJonas Björk
Jonas Björk
MCMarie Courbebaisse
Marie Courbebaisse
LCLionel Couzi
Lionel Couzi
NENatalie Ebert
Natalie Ebert
PDPierre Delanaye
Pierre Delanaye

1 April 2009 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
ARAndrew D. Rule
Andrew D. Rule
EBEric J. Bergstralh
Eric J. Bergstralh
LML. Joseph Melton
L. Joseph Melton
XLXujian Li
Xujian Li
AWAmy L. Weaver
Amy L. Weaver
JLJohn C. Lieske
John C. Lieske
Background and objectives: Kidney stones lead to chronic kidney disease (CKD) in people with rare hereditary disorders (e.g., primary hyperoxaluria, cystinuria), but it is unknown whether kidney stones are an important risk factor for CKD in the general population. Design, setting, participants, & measurements: Among Olmsted County, MN, residents, all stone formers (n = 4774) whose condition was diagnosed in 1986 through 2003 were matched 1:3 to control subjects (n = 12,975). Cox proportional hazards models adjusted for age, gender, and comorbidities (hypertension, diabetes, obesity, dyslipidemia, gout, alcohol abuse, tobacco use, coronary artery disease, heart failure, cerebral infarct, and peripheral vascular disease) were used to assess the risk for incident CKD defined as a clinical diagnosis (diagnostic codes), ESRD or death with CKD, sustained (>90 d) elevated serum creatinine (>1.3 mg/dl in men, >1.1 mg/dl in women), or sustained estimated GFR <60 ml/min per 1.73 m2. Results: During a mean of 8.6 yr of follow-up, stone formers were at increased risk for a clinical diagnosis of CKD, but an increased risk for ESRD or death with CKD was NS. Among patients with follow-up serum creatinine levels, stone formers were at increased risk for a sustained elevated serum creatinine and a sustained reduced GFR. Conclusions: Kidney stones are a risk factor for CKD, and studies are warranted to assess screening and preventive measures for CKD in stone formers.